Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 233,000 | 251,100 | 262,900 | 340,800 | 187,100 |
| Marketable Securities | 843,100 | 780,500 | 726,400 | 370,500 | 613,900 |
| Receivables | 479,100 | 439,300 | 350,000 | 185,500 | 157,100 |
| Inventories | 57,400 | 38,300 | 35,100 | 30,500 | 28,000 |
| Other current assets | 112,100 | 97,800 | 79,100 | 45,500 | 30,100 |
| TOTAL | $1,724,700 | $1,607,000 | $1,453,500 | $972,800 | $1,016,200 |
| Non-Current Assets | |||||
| PPE Net | 82,600 | 70,800 | 58,600 | 58,600 | 44,600 |
| Investments And Advances | 864,300 | 849,400 | 401,500 | 624,400 | 265,300 |
| Intangibles | 36,500 | 35,500 | 37,200 | 0 | 0 |
| Other Non-Current Assets | 1,010,600 | 688,700 | 417,900 | 416,700 | 408,600 |
| TOTAL | $1,994,000 | $1,644,400 | $915,200 | $1,099,700 | $718,500 |
| Total Assets | $3,718,700 | $3,251,400 | $2,368,700 | $2,072,500 | $1,734,700 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 461,600 | 448,800 | 347,600 | 225,800 | 168,700 |
| Other current liabilities | 46,100 | 35,900 | 20,700 | 20,000 | 17,800 |
| TOTAL | $507,700 | $654,800 | $537,700 | $245,800 | $186,500 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 335,100 | 317,900 |
| Other Non-Current Liabilities | 621,300 | 364,600 | 123,200 | 117,600 | 104,100 |
| TOTAL | $621,300 | $364,600 | $123,200 | $452,700 | $422,000 |
| Total Liabilities | $1,129,000 | $1,019,400 | $660,900 | $698,500 | $608,500 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 99,704 | 99,507 | 96,588 | 95,243 | 93,944 |
| Common Shares | 100 | 100 | 100 | 100 | 100 |
| Retained earnings | 29,200 | -157,100 | -406,800 | -635,800 | -725,400 |
| Other shareholders' equity | 5,800 | 7,000 | -7,900 | -1,700 | 1,800 |
| TOTAL | $2,589,700 | $2,232,000 | $1,707,800 | $1,374,000 | $1,126,200 |
| Total Liabilities And Equity | $3,718,700 | $3,251,400 | $2,368,700 | $2,072,500 | $1,734,700 |